5Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility TestingES:. M1011- $23,2013.
6Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia[J]. Clin Infect Dis,2010, 51 Suppl 1 :s81-s87.
7Falagas ME, Karageorgopoulos DE. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram negative bacilli: need for international harmonization in terminology[J]. Clin Infect Dis, 2008, 46(7): 1121-1122.
8Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twenty fourth informational supplement, 2014, M100-S24.
9Hu F, Chen S, Xu X, et al. Emergence of carbapenem- resistant Enterobacteriaceae clinical isolates from a teaching hospital in Shanghai, China[J]. J Med Microbiol, 2012, 61 (Pt 1): 132-136.
10Van Duin D, Kaye KS, Neuner EA, et al. Carbapenem-resistant Enterol2acteriaceae= a review of treatment and outcomes [J]. Diagn Microbiol Infect Dis, 2013, 75(2): 115-120.
